Balanced news tone
News Sentiment
VISTN sentiment intelligence
Vistin Pharma ASA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
68/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, -0.5% over four weeks, trend inactive, and near fair-value range.
Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 May 2026 07:00
- Source
- foreignpolicyjournal.com
Vistin Pharma ASA: First quarter 2026 financial results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Apr 2026 07:00
- Source
- GlobeNewswire
Vistin Pharma ASA: Third quarter and YTD 2025 financial results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 31 Oct 2025 07:00
- Source
- GlobeNewswire
Vistin Pharma ASA: First quarter 2025 financial results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2025 07:00
- Source
- GlobeNewswire
VISTN Stock Price and Chart — OSL:VISTN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2022 08:00
- Source
- TradingView
Vistin hands partner its opioid, CMO businesses
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2017 07:00
- Source
- BioPharma Dive